These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 589316)

  • 61. Factors affecting E-rosette forming ability in peripheral lymphocytes of insulin dependent diabetics.
    Cattaneo R; Saibene V; Pescatori D; Mersi A; Pozza G
    Diabetologia; 1980; 18(2):115-9. PubMed ID: 6245007
    [No Abstract]   [Full Text] [Related]  

  • 62. [Effect of upper abdominal autonomic denervation on glucagon secretion after intraduodenal glucose administration in dogs].
    Takaesu Y; Nimura Y; Hayakawa N; Ohtsuka K; Hayakawa T; Yasui K
    Nihon Shokakibyo Gakkai Zasshi; 1988 Feb; 85(2):252-9. PubMed ID: 3290547
    [No Abstract]   [Full Text] [Related]  

  • 63. Cardiovascular effects of insulin.
    Page MM; Smith RB; Watkins PJ
    Br Med J; 1976 Feb; 1(6007):430-2. PubMed ID: 766895
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Light Activated Glucagon Trimer with Resistance to Fibrillation.
    Chintala S; Friedman SH
    ACS Biomater Sci Eng; 2021 Apr; 7(4):1506-1514. PubMed ID: 33703874
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impaired glucose tolerance is associated with enhanced postprandial pancreatic polypeptide secretion.
    Zhao Y; Zhou Y; Xiao M; Huang Y; Qi M; Kong Z; Chi J; Che K; Lv W; Dong B; Wang Y
    J Diabetes; 2022 May; 14(5):334-344. PubMed ID: 35437937
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lack of glucagon response in glucose counter-regulation in type 1 (insulin-dependent) diabetics: absence of recovery after prolonged optimal insulin therapy.
    Bolli G; Calabrese G; De Feo P; Compagnucci P; Zega G; Angeletti G; Cartechini MG; Santeusanio F; Brunetti P
    Diabetologia; 1982 Feb; 22(2):100-5. PubMed ID: 7037510
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Status of pancreatic transplants and mechanical devices for blood glucose control in diabetes.
    Santiago JV; White NH
    Ann Biomed Eng; 1980; 8(4-6):525-38. PubMed ID: 6794390
    [No Abstract]   [Full Text] [Related]  

  • 68. Improved but not normalized glucose counter-regulation during glucagon infusion in Type 1 (insulin-dependent) diabetes.
    Lager I; von Schenck H; Smith U
    Diabetologia; 1984 May; 26(5):337-42. PubMed ID: 6376242
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.
    Bolli GB; Tsalikian E; Haymond MW; Cryer PE; Gerich JE
    J Clin Invest; 1984 Jun; 73(6):1532-41. PubMed ID: 6373827
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of glucose and insulin in the dynamic regulation of glucagon release by the perfused rat pancreas.
    Leclercq-Meyer V; Marchand J; Malaisse WJ
    Diabetologia; 1983 Mar; 24(3):191-5. PubMed ID: 6341147
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Counterregulation in type 2 (non-insulin-dependent) diabetes mellitus. Normal endocrine and glycaemic responses, up to ten years after diagnosis.
    Heller SR; Macdonald IA; Tattersall RB
    Diabetologia; 1987 Dec; 30(12):924-9. PubMed ID: 3325324
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy.
    Ryder RE; Owens DR; Hayes TM; Ghatei MA; Bloom SR
    BMJ; 1990 Oct; 301(6755):783-7. PubMed ID: 2224265
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autonomic dysfunction and severe hypoglycaemia in insulin dependent diabetes mellitus.
    Barkai L; Madácsy L; Vámosi I
    Arch Dis Child; 1991 Dec; 66(12):1438-41. PubMed ID: 1776893
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hormonal responses to insulin infusion in diabetes mellitus.
    Campbell LV; Kraegen EW; Meler H; Lazarus L
    Diabetologia; 1979 Jun; 16(6):359-64. PubMed ID: 467845
    [No Abstract]   [Full Text] [Related]  

  • 76. Impaired response of pancreatic polypeptide to hypoglycaemia: an early sign of autonomic neuropathy in diabetics.
    Krarup T; Schwartz TW; Hilsted J; Madsbad S; Verlaege O; Sestoft L
    Br Med J; 1979 Dec; 2(6204):1544-6. PubMed ID: 394798
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diabetic autonomic neuropathy.
    Clarke BF; Ewing DJ; Campbell IW
    Diabetologia; 1979 Oct; 17(4):195-212. PubMed ID: 387501
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Can beta-blockers be used in diabetic patients?
    Waal-Manning HJ
    Drugs; 1979 Mar; 17(3):157-60. PubMed ID: 37063
    [No Abstract]   [Full Text] [Related]  

  • 79. Defective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy.
    Campbell LV; Kraegen EW; Lazarus L
    Br Med J; 1977 Dec; 2(6101):1527-9. PubMed ID: 589316
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lack of glucagon response to hypoglycemia in diabetic autonomic neuropathy.
    Maher TD; Tanenberg RJ; Greenberg BZ; Hoffman JE; Doe RP; Goetz FC
    Diabetes; 1977 Mar; 26(3):196-200. PubMed ID: 838171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.